Budesonide Oxoacetic Acid
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Budesonide Oxoacetic Acid

● In Stock

Catalogue No.:VE007474
CAS No.:N/A
Mol. Formula:C25H32O7
Mol. Weight:444.52 g/mol

Additional information on Budesonide Oxoacetic Acid

Parent drug

Budesonide

IUPAC Name

2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-Hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetic acid

Synonyms

Budesonide Related Compound 5

Description

Budesonide Oxoacetic Acid, also designated Budesonide Related Compound 5, is an oxidative degradant of the corticosteroid budesonide arising from side-chain oxidation to a ketocarboxylic acid motif. This impurity is not a nitrosamine or mutagenic alkylating species, yet its presence is relevant for impurity profiling and stability assessment under pharmaceutical regulatory expectations. The compound has formula C25H32O7 and molecular weight 444.52 g/mol. Owing to closely related steroidal polarity and limited UV selectivity, determination commonly requires LC-MS/MS with confirmatory high-resolution mass spectrometry, complemented by chromatographic resolution on reversed-phase systems and, where necessary, NMR characterization of the oxoacetic functionality.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url